Introduction {#Sec1}
============

The understanding of stress urinary incontinence (SUI) pathophysiology has consistently improved over the past decade, resulting in the development of many surgical techniques. Based on the Integral Theory, Petros and Ulmsten proposed the tension-free vaginal tape (TVT). According to this theory, a midurethral tape can stabilize the urethra during straining without modifying urethral mobility \[[@CR1], [@CR2]\]. Ulmsten first introduced the TVT procedure for female SUI in 1995 \[[@CR1]\], and it soon became known worldwide, with a reported cure rate of \>80 % \[[@CR2]\]. Despite this cure rate, major complications, such as injuries to the bowel and major blood vessels, have been described \[[@CR3]\].

Palma introduced the Arc-to-Arc minisling as an alternative to the TVT procedure in 1999 \[[@CR4]\]. In 2001, Delorme developed the transobturator tape (TOT) technique \[[@CR5]\] to reduce perioperative complications related to the blind passage of needles in the retropubic space. Several studies reported high cure and low complication rates for TOT and, based on preoperative urodynamic findings and postoperative clinical examination, uroflowmetry, and cough test, the authors discussed the mechanisms responsible for the success of this treatment \[[@CR6], [@CR7]\]. Continence rate with the transobturator approach is reportedly similar to that obtained with the transvaginal retropubic approach \[[@CR6], [@CR7]\]. Most of the described complications of retropubic slings are related to the blind nature of these procedures \[[@CR8]\].

The Ophira Mini Sling System is an innovative anatomical approach that involves anchoring a midurethral low-tension tape to the obturator internus muscles bilaterally at the level of the tendinous arc through a single vaginal incision. Its rationale is to reinforce the urethropelvic ligament with a transobturator tape. Although a recent publication has shown that minislings are as effective in nonobese as in obese patients, the ideal subset of patients for this procedure is still to be defined \[[@CR9]\]. This study aimed to identify the most suited subset of patients for the Ophira procedure.

Materials and methods {#Sec2}
=====================

An international, multicentric, prospective, open-label, single-arm, clinical study was carried out in two countries to assess the clinical performance of the Ophira Mini Sling System for treating female SUI. The local ethical committees approved the study, and all patients signed written informed consent. Only patients older than 18 years with clinical and urodynamic diagnosis of SUI and with absence of neurological disease and clinically significant detrusor overactivity were included. Exclusion criteria were urodynamic changes suggesting a reduction in bladder capacity; bladder compliance of or suggestive of bladder outlet obstruction; coagulopathies; pregnancy; history of sensitivity to foreign materials; acute urinary tract infection; acute vulvovaginitis; sequelae of exposure to ionizing radiation; use of drugs that can result in high surgical risk or risk of significant postoperative complications, including any drug that interferes with blood clotting; and contraindication to anesthetic procedure. Data were collected from 124 women, all of whom completed at least 1 year of follow-up; 95 (76.6 %) completed 2 years of follow-up. Workup included history, physical examination, stress test, standardized 1-h pad-weight test (PWT), and preoperative urodynamic study. Patients were also evaluated with two validated questionnaires: the International Consultation on Incontinence Questionnaire--Short Form (ICIQ-SF), and Urogenital Distress Inventory (UDI-6). During postoperative follow-up, patients were reviewed at 1, 3, 6, 12, and 24 months. For this analysis, 12- and 24-month data were compared to assess the durability of clinical outcomes. Objective cure of SUI (dry patients) was defined as urinary leakage \<1 g in the 1-h PWT \[[@CR10]\], whereas improvement was defined as leakage \<50 % of the preoperative value. Any greater urinary leakage was defined as treatment failure \[[@CR11]\].

Single-incision minislings (SIMS) were used to treat SUI (Ophira Mini Sling System; Promedon, Córdoba, Argentina) composed of polypropylene monofilament mesh (type I) and relies on two self-anchoring polypropylene multipoint fixation arms for tissue fixation. A retractable insertion guide (RIG) is used to ensure accurate insertion. The RIG has two fixation points at its tip that act as an antirotational system (Fig. [1a](#Fig1){ref-type="fig"}--[c](#Fig1){ref-type="fig"}).Fig. 1**a**--**c** Surgical set. Detail of Ophira Mini Sling System antirotational tip and retractable insertion guide

The surgical procedure was generally carried out under local anesthesia, with 20 ml of 2 % lidocaine being injected at the midurethral point toward the vaginal fornix and advancing 2 cm into the obturator internus muscles. General or spinal anesthesia were less commonly used but were selected for some particular cases. A vertical, 2-cm vaginal incision was performed 1 cm from the urethral meatus. Minimal dissection was performed laterally toward the ascending ramus of the pubic bone, preserving the endopelvic fascia. Prior to implant insertion, a RIG was connected to a multipoint fixation arm. Guided by the surgeon's index finger, the guide was introduced behind the ascending ramus of the pubic bone toward the obturator internus muscle, 1 cm above the vaginal fornix. When the centering mark of the implant was underneath the urethra, the trigger on the handle was deployed to release the fixation arm and set it in place. The design of the multipoint fixation arm provides strong and stable primary fixation \[[@CR12]\]. The same maneuvers were repeated on the other side. After fine adjustment of the mesh, the RIG was removed and the vaginal wall closed in the usual manner (Fig. [2](#Fig2){ref-type="fig"}). Cystoscopy was not mandatory but can be advised for patients with recurrent incontinence or based on the surgeon's intraoperative decision. No Foley catheters were left in place. Patients were discharged immediately after spontaneous voiding.Fig. 2**a** Local anesthesia; **b** vaginal incision; **c** dissection laterally toward the ascending ramus of the ischiopubic bone; **d**, **e** mesh insertion; **f** intraoperative stress test; **g** removal of retractable insertion guide; **h** fine adjustment of the mesh; **i** end of the procedure

Statistical analyses were performed with SPSS® 17 (Chicago, IL, USA). Continuous variables were compared with Student's independent *t* test for transverse analysis and paired sample test for longitudinal analysis. Categorical variables were tested with the *Χ*^2^ test for transverse analysis and the McNemar test when comparing pre- and postoperative values for the same subset of patients. Odds ratios (OR) for treatment failure at 2 years were also calculated. The main analysis was done to identify baseline factors that could predict surgical failure. For this purpose, an exploratory univariate analysis was performed, and posteriorly, a multivariate model was constructed (logistic regression), with variables of age, parity, body mass index (BMI), and Valsalva leak-point pressure (VLPP). A complementary longitudinal analysis was carried out to assess outcome stability over time. Data from the 1-and 2-year follow-ups were compared to fulfill this requirement. The level of statistical significance was fixed at \<0.05 for all comparisons.

Results {#Sec3}
=======

One hundred and twenty-four patients completed 1 year of follow-up, and 95 complied with the 2-year follow-up evaluation. Relevant patient variables are shown in Table [1](#Tab1){ref-type="table"}. Surgeries were done under local anesthesia in 90 (72.6 %) cases. Mean \[standard deviation (SD)\] operative time was 17.0 (7.1) min.Table 1Relevant baseline clinical variables for all participants (*n* = 124)VariablesResultsPrevious anti-incontinence surgeries, *n* (%)35 (28.2)^a^Age, mean (SD) \[years\]54.8 (9.9)Previous gestation, mean (SD)3.0 (2.0)Postmenopause, *n* (%)80 (64.5)VLPP, median (range)77.0 (25.0--147.0)Mixed urinary incontinence, *n* (%)51 (41.1)Body mass index, kg/cm^2^, mean (SD) \[\]27.9 (4.6)^a^Twenty-eight of these patients reached 2-year follow-up. This is the number used for further analysis of naïve and previously operated patients

Results from the longitudinal overall analyses are presented in Table [2](#Tab2){ref-type="table"}. There were no significant differences between 1- and 2-year follow-up data for mean PWT and CST or mean ICIQ-SF and UDI-6 scores.Table 2Comparison between objective and subjective 1- and 2-year follow-up outcomesVariablesPreoperative (*n* = 124)1 year (*n* = 124)2 years (*n* = 95)*P* value (1 vs 2 years)1-h PWT^a,b^Mean (SD)12.5 (15.4)1.4 (5.9)2.2 (9.1)0.477^c^Dry, *n* (%)NA103 (83.1)81 (85.3)Improvement, *n* (%)NA9 (7.3)6 (6.3)0.368^d^Failure, *n* (%)NA12 (9.7)8 (8.4)CST^a^Negative, *n* (%)0 (0)112 (90.3)82 (86.3)0.508^d^Positive, *n* (%)124 (100)12 (9.7)13 (13.7)ICIQ-SF^a^Mean (SD)15.8 (3.9)3.0 (5.1)1.9 (4.3)0.148^b^UDI-6^a^Mean (SD)9.2 (3.1)2.3 (3.0)1.7 (2.2)0.106^b^*PWT* pad weight test,*CST* cough stress test,*ICIQ-SF* International Consultation on Incontinence Questionnaire--Short Form,*UDI-6* Urinary Distress Inventory,*SD* standard deviation^a^Postoperative and preoperative records were compared using Student's two-tailed, dependent *t* test for continuous variables and McNemar test for CST. All the comparisons resulted in *p* \< 0.0005^b^For the 1- and 2-year follow-ups, there were four and three missing data; we considered these as failed because the last failure was carried forward^c^One- and 2-year comparison with Student's two-tailed independent *t* test^d^One- and 2-year comparison with Student's independent *t* test (PWT) and McNemar-Bowker test (CST)

To evaluate the effects of baseline factors on Ophira procedure outcomes, an exploratory univariate analysis was done prior to a logistic regression analysis, both summarized in Table [3](#Tab3){ref-type="table"}. The numerical variables of age, parity, BMI, and VLPP were transformed in dichotomous variables for these analyses. The two categories for each new variable were as follows: age ≥60 and \<60 years, BMI ≥30 and \<30 kg/m^2^, parity ≥3 and \<3 gestations, and VLPP ≥60 and \<60 cmH~2~O. Univariate analysis showed that only one factor was significantly associated with surgical failure: previous anti-incontinence surgeries (OR 4.0, *p* = 0.032). This finding was also confirmed after running a logistic regression model, where previous anti-incontinence surgeries remained the only variable significantly associated with surgical failure (OR 7.7, *p* = 0.04).Table 3Univariate and multivariate analysisFactorN~failed~/N~factor~ (%)Univariate analysisMultivariate analysisOR (95 % CI)*P* valueOR (95 % CI)*P* valuePrevious surgery5/28 (17.9)4.00 (1.02--15.57)0.032\*7.7 (1.1--53.6)0.04\*Age ≥60 years3/31 (9.7)1.26 (0.32--4.85)0.759VLPP \<60 cmH~2~O4/30 (13.3)4.31 (0.74--25.04)0.081BMI ≥30 kg/m^2^4/25 (16.0)2.81 (0.64--12.25)0.156Mixed incontinence2/29 (6.9)0.74 (0.14--3.91)0.723Menopause6/53 (10.2)1.83 (0.35--9.62)0.468Parity ≥33/47 (6.4)0.56 (0.13--2.49)0.440*VLPP* Valsalva leak-point pressure,*BMI* body mass index,*OR* odds ratio,*CI* confidence interval^a^Postoperative and preoperative records were compared using Student's two-tailed, dependent *t* test for continuous variables and McNemar test for CST. All the comparisons resulted in *p* \< 0.0005^b^For the 1- and 2-year follow-ups, there were four and three missing data; we considered these as failed because the last failure was carried forward^c^One- and 2-year comparison with Student's two-tailed independent *t* test^d^One- and 2-year comparison with Student's independent *t* test (PWT) and McNemar-Bowker test (CST)\*Statistically significant

After the identification of previous surgeries as the only risk factor for surgical failure, the 2-year results were segmented according to this factor. Figure [3](#Fig3){ref-type="fig"} depicted the percentages of cured, improved and failed cases within the following groups: overall results, naïve and previously operated patients. Table [4](#Tab4){ref-type="table"} showed the comparison of failure rates between those patients who received a previous anti-incontinence surgery and those who did not. Naïve women achieved a significantly higher success rate than did patients who had previously undergone surgery according both to PWT and CST (*p* = 0.032 and *p* = 0.038 respectively). On the other hand, there was not a statistically significant difference between these groups in UDI-6 scores. The mean (SD) UDI-6 score for the previously operated women was 2.5 (3.1) and for naïve patients 1.4 (1.6), *p* = 0.07.Fig. 3Success rates according to pad weight test (PWT) for the segmented sampleTable 4Results stratified according to the risk factor of previous anti-incontinence surgeryVariables (*n*)Failure according to PWTPositive CSTICIQ-SFUDI-6*n* (%)*P* value^*a*^*n* (%)*P* value^*a*^Mean (SD)*P* value^*b*^Mean (SD)*P* value^*b*^Previous surgery (28)5 (17.9)0.032\*7 (25.0)0.038\*4.4 (6.4)0.019\*2.5 (3.1)0.070Naïve patients (67)3 (4.5)6 (9.0)0.8 (2.2)1.4 (1.6)^a^Χ^2^ test^b^Independent Student's *t* test\*Statistically significant

Within the operating room, three patients had symptoms of lidocaine hydrochloride overdose for which they were treated conservatively. One woman who underwent local anesthesia experienced severe intraoperative pain and needed intravenous sedation. There was no severe intraoperative bleeding or organ perforation (urethra, bladder, bowel, vessels). There was no infection, hematoma, or dyspareunia during follow-up. Sling exposure was observed in four patients (3.2 %), all \<0.5 cm in diameter. Two of these patients were treated with local estrogen with good results and two by ambulatory resection. Four patients had urinary retention (3.2 %), which resolved spontaneously in two and treated by mesh incision in one and by sling loosening in one. Nine patients (7.3 %) presented de novo urgency; all were treated initially with anticholinergics.

Discussion {#Sec4}
==========

Understanding physiopathological concepts of SUI has consistently improved over recent years, and treatment options have led to the development of many different surgical techniques. In the past decade, minimally invasive synthetic slings have replaced Burch colposuspension to become the preferred technique for treating SUI \[[@CR13], [@CR14]\]. The driving aim of minislings is to reduce complications. In an attempt to reduce major problems, a new means of anatomical reconstruction of urethral support has been described; namely, the tissue fixation system. This reconstruction is achieved by bilaterally anchoring a low-tension suburethral tape to the obturator internus muscles at the level of the tendinous arc \[[@CR8]\]. This procedure minimizes injuries to bowel and major vessels.

In our first study of the SIMS in 1999, we used bovine pericardium and obtained good initial results; however, there was an unacceptable rate of extrusion after 6 months \[[@CR4]\]. This problem was later confirmed by a clinical trial using bovine pericardial slings in which a 90 % rate of postoperative complications was reported \[[@CR15]\]. Persisting with the principle of restoring the urethropelvic ligament, we reported the results of using porcine small-intestinal submucosa in 25 patients in 2001 \[[@CR16]\]. The Arc-to-Arc mini sling using swine intestinal submucosa produced 60 % good results in the long term (6 years' follow-up) \[[@CR17]\]. In addition to the use of a single incision, other valuable advantages of this procedure are that it is generally performed under local anesthesia and is a quick and truly outpatient procedure.

A recently published meta-analysis compared SIMS with both retropubic and transobturator standard midurethral slings (SMUS) \[[@CR18]\]. It is important to mention that 71 % of patients in the SIMS group received TVT Secur, the first SIMS commercially available, which has been associated with poor results. Moreover, a previous experimental study that highlighted the key importance of an effective primary fixation system for achieving good results with minislings showed that TVT Secur in particular is associated with delayed and less intense adherence to host tissue after implantation \[[@CR12]\]. In subsequent studies, a later generation of SIMS showed substantially better results than TVT Secur. In these later series, the Ophira and Miniarc procedures produced comparable results \[[@CR19]--[@CR21]\].

However, the ideal patient for a minisling is still to be determined. To answer this question, we stratified patients as naïve, those who had previously undergone anti-incontinence procedures that had failed, and by age, setting the age of 60 years as the threshold. We obtained the best results in naïve patients (89.6 % cures). For elderly patients, the objective cure rate was 80.6 %, which resulted in a nonsignificant OR for failure of 2.0 (95 % 0.55--7.71). Although our results in the elderly are quite acceptable and not significantly different from those of younger patients, many studies have reported less than optimal results in the former subset of patients. In a previous study, the authors concluded that TVT in elderly patients (\> 70 years) results in less favorable outcomes \[[@CR22]\]. Because of low complication rates, bulking agents are frequently indicated for the elderly and patients who are unsuitable for surgery, even though they produce lower continence rates than SMUS \[[@CR23]\]. The favorable results in elderly patients in our study indicate that this rationale (for bulking agent use) might also be considered for SIMS. Nevertheless, data from a randomized controlled trial are necessary to confirm or reject this possibility.

In clinical settings, the risk of failure must be related to safety. Many studies report an incidence of bladder perforation of 1--15 % and an average perforation rate of 5 % with a retropubic approach. On the other hand, transobturator slings have a lower rate of bladder and urethral injury during needle passage, which generally occurs in \<1 % of patients, but this type of device usually causes groin pain. Bleeding, another important complication, occurs mainly during needle passage \[[@CR13]\]. Bleeding upon entry into the retropubic space or the obturator internus muscles (in the transobturator route) can be difficult to manage. Moreover, some major complications, such as bowel and vascular injuries, as well as deaths have been reported \[[@CR3]\]. Most of the described major complications are related to the blind nature of these procedures \[[@CR8]\]. In this Ophira study, there were no cases of severe intraoperative bleeding, organ injury, or persistent pain. We consider that the absence of major complications in this series is attributable to reduction of the main risk factors; namely, reduction in blind passage of needles, the need for only one incision, and the relatively small extent of tissue dissection (considerably smaller than with SMUS).

For patients who had previously undergone surgery, the success rate was 67.9 % and the OR for failure 4.0 (95 % CI 1.02--15.57). In a prospective study of TVT in 34 women with recurrent SUI, the cure rate was 82 % \[[@CR22]\]. However, several studies using retropubic or transobturator slings failed to reproduce this high success rate for recurrent SUI, reporting cure rates ranging from 62 % to 74 % \[[@CR24]--[@CR27]\]. It is important to note that patients with good urethral mobility did better than those with fixed urethras.

To our knowledge, this is the first report of results of using minislings for recurrent SUI. Our results are similar to those reported for TVT or TOT in this subset of patients. Although our overall results are satisfactory, we stress that we achieved significantly better outcomes in the naïve group of patients.

In conclusion, the Ophira Mini Sling System is a safe and effective option for treating SUI and attans durable good results. The ideal candidates for this technique are naïve patients; previous surgeries were identified as the only significant risk factor, though previously operated patients showed an acceptable success rate.
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